Sinha Neeraj
Houston Methodist Hospital, Houston, Texas.
Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4 Suppl):18-20. doi: 10.14797/mdcj-12-4s1-18.
Roughly 10% of lung transplant recipients experience airway complications. Although the incidence has decreased dramatically since the first lung transplants were performed in the 1960s, airway complications have continued to adversely affect outcomes. Bronchoscopic interventions such as balloon dilation, airway stenting, and endobronchial electrocautery play an important role in ameliorating the morbidity and mortality associated with these complications. This review describes the array of bronchoscopic interventions used to treat airway complications after lung transplant and how these techniques can be used in nontransplant settings as well.
大约10%的肺移植受者会出现气道并发症。尽管自20世纪60年代首次进行肺移植以来,其发病率已大幅下降,但气道并发症仍继续对治疗结果产生不利影响。诸如球囊扩张、气道支架置入和支气管内电灼等支气管镜干预措施在改善与这些并发症相关的发病率和死亡率方面发挥着重要作用。这篇综述描述了用于治疗肺移植后气道并发症的一系列支气管镜干预措施,以及这些技术如何也能应用于非移植环境。